130 related articles for article (PubMed ID: 14615985)
21. Hyperforin modifies neuronal membrane properties in vivo.
Eckert GP; Keller JH; Jourdan C; Karas M; Volmer DA; Schubert-Zsilavecz M; Müller WE
Neurosci Lett; 2004 Sep; 367(2):139-43. PubMed ID: 15331138
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
Hokkanen J; Tolonen A; Mattila S; Turpeinen M
Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
[TBL] [Abstract][Full Text] [Related]
23. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
Biber A; Fischer H; Römer A; Chatterjee SS
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
[TBL] [Abstract][Full Text] [Related]
24. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S
Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
Wonnemann M; Singer A; Müller WE
Neuropsychopharmacology; 2000 Aug; 23(2):188-97. PubMed ID: 10882845
[TBL] [Abstract][Full Text] [Related]
26. High-performance liquid chromatography-electrospray ionization mass spectrometry and multiple mass spectrometry studies of hyperforin degradation products.
Fuzzati N; Gabetta B; Strepponi I; Villa F
J Chromatogr A; 2001 Aug; 926(1):187-98. PubMed ID: 11554411
[TBL] [Abstract][Full Text] [Related]
27. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
[TBL] [Abstract][Full Text] [Related]
28. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
Butterweck V; Winterhoff H; Herkenham M
Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
[TBL] [Abstract][Full Text] [Related]
29. Structural investigations of isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn.
Wolfender JL; Verotta L; Belvisi L; Fuzzati N; Hostettmann K
Phytochem Anal; 2003; 14(5):290-7. PubMed ID: 14516001
[TBL] [Abstract][Full Text] [Related]
30. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
[TBL] [Abstract][Full Text] [Related]
31. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Schober F; Mannel M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
[TBL] [Abstract][Full Text] [Related]
32. A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pre-clinical pharmacokinetic study.
Chakradhar L; Kallem R; Karthik A; Sundari BT; Ramesh S; Mullangi R; Srinivas NR
Biomed Chromatogr; 2008 Jan; 22(1):58-63. PubMed ID: 17642067
[TBL] [Abstract][Full Text] [Related]
33. High-performance liquid chromatography measurement of hyperforin and its reduced derivatives in rodent plasma.
Rozio M; Fracasso C; Riva A; Morazzoni P; Caccia S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):21-7. PubMed ID: 15664329
[TBL] [Abstract][Full Text] [Related]
34. A simple and reliable semipreparative high-performance liquid chromatography technique for the isolation of marker-grade hyperforin from Hypericum perforatum L extract.
Anand R; Puri SC; Verma N; Handa G; Khajuria RK; Gupta VK; Suri OP; Qazi GN
J Chromatogr Sci; 2003 Sep; 41(8):444-6. PubMed ID: 14558939
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
[TBL] [Abstract][Full Text] [Related]
36. No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.
Mueller SC; Majcher-Peszynska J; Mundkowski RG; Uehleke B; Klammt S; Sievers H; Lehnfeld R; Frank B; Thurow K; Kundt G; Drewelow B
Eur J Clin Pharmacol; 2009 Jan; 65(1):81-7. PubMed ID: 18762932
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
[TBL] [Abstract][Full Text] [Related]
38. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
[TBL] [Abstract][Full Text] [Related]
39. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
40. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
